References
- Agwuh, K. N., & MacGowan, A. (2006). Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. The Journal of Antimicrobial Chemotherapy, 58(2), 256–265. https://doi.org/https://doi.org/10.1093/jac/dkl224
- Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., & Hilgenfeld, R. (2003). Coronavirus main proteinase (3CLpro) structure: Basis for design of anti-SARS drugs. Science (New York, N.Y.), 300(5626), 1763–1767. https://doi.org/https://doi.org/10.1126/science.1085658
- Andriole, G. L., & Kirby, R. (2003). Safety and tolerability of the dual 5 alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia. European Urology, 44(1), 82–88. https://doi.org/https://doi.org/10.1016/S0302-2838(03)00198-2
- Annane, D., Decaux, G., Smith, N., & Grp, C. S. (2009). Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia. The American Journal of the Medical Sciences, 337(1), 28–36. https://doi.org/https://doi.org/10.1097/MAJ.0b013e31817b8148
- Armutlu, P., Ozdemir, M. E., Ozdas, S., Kavakli, I. H., & Turkay, M. (2009). Discovery of novel CYP17 inhibitors for the treatment of prostate cancer with structure-based drug design. Letters in Drug Design & Discovery, 6(5), 337–344. https://doi.org/https://doi.org/10.2174/1570180810906050337
- Boopathi, S., Poma, A. B., & Kolandaivel, P. (2020). Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/10.1080/07391102.2020.1758788.
- Çakir, B., Dağliyan, O., Dağyildiz, E., Bariş, İ., Kavakli, I. H., Kizilel, S., & Türkay, M. (2012). Structure based discovery of small molecules to regulate the activity of human insulin degrading enzyme. PLoS One, 7(2), e31787. https://doi.org/https://doi.org/10.1371/journal.pone.0031787
- Chan, J. F., Chik, K. K., Yuan, S., Yip, C. C., Zhu, Z., Tee, K. M., Tsang, J. O., Chan, C. C., Poon, V. K., Lu, G., Zhang, A. J., Lai, K. K., Chan, K. H., Kao, R. Y., & Yuen, K. Y. (2017). Novel antiviral activity and mechanism of bromocriptine as a Zika virus NS2B-NS3 protease inhibitor. Antiviral Research, 141, 29–37. https://doi.org/https://doi.org/10.1016/j.antiviral.2017.02.002
- Christie, S., Gobel, H., Mateos, V., Allen, C., Vrijens, F., Shivaprakash, M., & Pr, R. E. C. (2003). Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine. European Neurology, 49(1), 20–29. https://doi.org/https://doi.org/10.1159/000067018
- Clark, R. V., Hermann, D. J., Cunningham, G. R., Wilson, T. H., Morrill, B. B., & Hobbs, S. (2004). Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. Journal of Clinical Endocrinology and Metabolism, 89(5), 2179–2184. https://doi.org/https://doi.org/10.1210/jc.2003-030330
- Case, D. A., I. Y. B.-S., Brozell, S. R., Cerutti, D. S., Cheatham, T. E., III, Cruzeiro, V. W. D., Darden, T. A., Duke, R. E., Ghoreishi, D., Gilson, M. K., Gohlke, H., Goetz, A. W., Greene, D., Harris, R., Homeyer, N., Izadi, S., Kovalenko, A., Kurtzman, T., Lee, T. S. … Kollman, (2018). 208. AMBER. University of California.
- Das, S., Sarmah, S., Lyndem, S., & Singha Roy, A. (2020). An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/https://doi.org/10.1080/07391102.2020.1763201
- Davidson, M., Emsley, R., Kramer, M., Ford, L., Gassmann-Mayer, C., Lim, P., Pan, J., & Eerdekens, M. (2006). Efficacy, safety and effect on functioning of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: An International 6-week placebo-controlled study. Schizophrenia Research, 81, 43–43.
- De Clercq, E. (2007). The design of drugs for HIV and HCV. Nature Reviews Drug Discovery, 6(12), 1001–1018. https://doi.org/https://doi.org/10.1038/nrd2424
- DeLano, W. L. (2009). PyMOL molecular viewer: Updates and refinements. In Abstracts of papers of the American Chemical Society (Vol. 238). American Chemical Society.
- Deng, Y., Madatian, A., Wire, M. B., Bowen, C., Park, J. W., Williams, D., Peng, B., Schubert, E., Gorycki, F., Levy, M., & Gorycki, P. D. (2011). Metabolism and disposition of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist, in healthy human subjects. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 39(9), 1734–1746. https://doi.org/https://doi.org/10.1124/dmd.111.040170
- Diener, H. C., Jansen, J. P., Reches, A., Pascual, J., Pitei, D., Steiner, T. J., & St, E. C. C. (2002). Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot (R)) in the acute treatment of migraine: A multicentre, randomised, double-blind, placebo-controlled comparison. European Neurology, 47(2), 99–107. https://doi.org/https://doi.org/10.1159/000047960
- Doruk, Y. U., Yarparvar, D., Akyel, Y. K., Gul, S., Taskin, A. C., Yilmaz, F., Baris, I., Ozturk, N., Turkay, M., Ozturk, N., Okyar, A., & Kavakli, I. H. (2020). A CLOCK-binding small molecule disrupts the interaction between CLOCK and BMAL1 and enhances circadian rhythm amplitude. The Journal of Biological Chemistry, 295(11), 3518–3531. https://doi.org/https://doi.org/10.1074/jbc.RA119.011332
- Drosten, C., Gunther, S., Preiser, W., van der Werf, S., Brodt, H. R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A., Berger, A., Burguiere, A. M., Cinatl, J., Eickmann, M., Escriou, N., Grywna, K., Kramme, S., Manuguerra, J. C., Muller, S., … Doerr, H. W. (2003). Identification of a novel coronavirus in patients with severe acute respiratory syndrome. The New England Journal of Medicine, 348(20), 1967–1976. https://doi.org/https://doi.org/10.1056/NEJMoa030747
- Dyall, J., Gross, R., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Hensley, L. E., Frieman, M. B., & Jahrling, P. B. (2017). Middle East respiratory syndrome and severe acute respiratory syndrome: Current therapeutic options and potential targets for novel therapies. Drugs, 77(18), 1935–1966. https://doi.org/https://doi.org/10.1007/s40265-017-0830-1
- Erickson-Miller, C. L., Delorme, E., Tian, S. S., Hopson, C. B., Landis, A. J., Valoret, E. I., Sellers, T. S., Rosen, J., Miller, S. G., Luengo, J. I., Duffy, K. J., & Jenkins, J. M. (2009). Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist. Stem Cells (Dayton, Ohio), 27(2), 424–430. https://doi.org/https://doi.org/10.1634/stemcells.2008-0366
- Firth, A. E., & Brierley, I. (2012). Non-canonical translation in RNA viruses. The Journal of General Virology, 93(Pt 7), 1385–1409. https://doi.org/https://doi.org/10.1099/vir.0.042499-0
- Gantt, S., Casper, C., & Ambinder, R. F. (2013). Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and prevention. Current Opinion in Oncology, 25(5), 495–502. https://doi.org/https://doi.org/10.1097/CCO.0b013e328363dfee
- Ghali, J. K., Koren, M. J., Taylor, J. R., Brooks-Asplund, E., Fan, K., Long, W. A., Smith, N., & Grp, C. S. (2006). Efficacy and safety of oral conivaptan: A V-1A/V-2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia. The Journal of Clinical Endocrinology & Metabolism, 91(6), 2145–2152. https://doi.org/https://doi.org/10.1210/jc.2005-2287
- Gorbalenya, A. E., Enjuanes, L., Ziebuhr, J., & Snijder, E. J. (2006). Nidovirales: Evolving the largest RNA virus genome. Virus Research, 117(1), 17–37. https://doi.org/https://doi.org/10.1016/j.virusres.2006.01.017
- Graham, R. L., Sparks, J. S., Eckerle, L. D., Sims, A. C., & Denison, M. R. (2008). SARS coronavirus replicase proteins in pathogenesis. Virus Research, 133(1), 88–100. https://doi.org/https://doi.org/10.1016/j.virusres.2007.02.017
- Habibzadeh, P., & Stoneman, E. K. (2020). The novel coronavirus: A bird's eye view. The International Journal of Occupational and Environmental Medicine, 11(2), 65–71. https://doi.org/https://doi.org/10.15171/ijoem.2020.1921
- He, Y. F., Lian, S. J., & Dong, Y. C. (2020). Clinical characteristics, diagnosis, and treatment of COVID-19: A case report. World Journal of Clinical Cases, 8(11), 2325–2331. https://doi.org/https://doi.org/10.12998/wjcc.v8.i11.2325
- Hoffmann, M., Kleine-Weber, H., Schroeder, S., Kruger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N. H., Nitsche, A., Muller, M. A., Drosten, C., & Pohlmann, S. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181(2), 271–280. https://doi.org/https://doi.org/10.1016/j.cell.2020.02.052
- Huang, J., Rauscher, S., Nawrocki, G., Ran, T., Feig, M., de Groot, B. L., Grubmuller, H., & MacKerell, A. D. Jr., (2017). CHARMM36m: An improved force field for folded and intrinsically disordered proteins. Nature Methods, 14(1), 71–73. https://doi.org/https://doi.org/10.1038/nmeth.4067
- Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38. https://doi.org/https://doi.org/10.1016/0263-7855(96)00018-5
- Irwin, J. J., & Shoichet, B. K. (2005). ZINC-a free database of commercially available compounds for virtual screening. Journal of Chemical Information and Modeling, 45(1), 177–182. https://doi.org/https://doi.org/10.1021/ci049714+
- Islam, R., Parves, M. R., Paul, A. S., Uddin, N., Rahman, M. S., Mamun, A. A., Hossain, M. N., Ali, M. A., & Halim, M. A. (2020). A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 1–12. https://doi.org/https://doi.org/10.1080/07391102.2020.1761883
- Janicak, P. G., & Winans, E. A. (2007). Paliperidone ER: A review of the clinical trial data. Neuropsychiatric Disease and Treatment, 3(6), 869–897. https://doi.org/https://doi.org/10.2147/ndt.s1365
- Jeon, S., Ko, M., Lee, J., Choi, I., Young Byun, S., Park, S., Shum, D., Kim, S. (2020). Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs. Antimicrobial Agents and Chemotherapy, 1–9. https://doi.org/https://doi.org/10.1101/2020.03.20.999730.
- Jo, S., Kim, T., Iyer, V. G., & Im, W. (2008). CHARMM-GUI: A web-based graphical user interface for CHARMM. Journal of Computational Chemistry, 29(11), 1859–1865. https://doi.org/https://doi.org/10.1002/jcc.20945
- Kato, F., Ishida, Y., Oishi, S., Fujii, N., Watanabe, S., Vasudevan, S. G., Tajima, S., Takasaki, T., Suzuki, Y., Ichiyama, K., Yamamoto, N., Yoshii, K., Takashima, I., Kobayashi, T., Miura, T., Igarashi, T., & Hishiki, T. (2016). Novel antiviral activity of bromocriptine against dengue virus replication. Antiviral Research, 131, 141–147. https://doi.org/https://doi.org/10.1016/j.antiviral.2016.04.014
- Khan, R. J., Jha, R. K., Amera, G. M., Jain, M., Singh, E., Pathak, A., Singh, R. P., Muthukumaran, J., & Singh, A. K. (2020). Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2'-O-ribose methyltransferase. Journal of Biomolecular Structure and Dynamics, 1–14. https://doi.org/https://doi.org/10.1080/07391102.2020.1753577
- Kim, S., Lee, J., Jo, S., Brooks, C. L., 3rd, Lee, H. S., & Im, W. (2017). CHARMM-GUI ligand reader and modeler for CHARMM force field generation of small molecules. Journal of Computational Chemistry, 38(21), 1879–1886. https://doi.org/https://doi.org/10.1002/jcc.24829
- Kirchdoerfer, R. N., & Ward, A. B. (2019). Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors. Nature Communications, 10(1), 2342. https://doi.org/https://doi.org/10.1038/s41467-019-10280-3
- Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., Tong, S., Urbani, C., Comer, J. A., Lim, W., Rollin, P. E., Dowell, S. F., Ling, A. E., Humphrey, C. D., Shieh, W. J., Guarner, J., Paddock, C. D., Rota, P., Fields, B., … Group, S. W. (2003). A novel coronavirus associated with severe acute respiratory syndrome. New England Journal of Medicine, 348(20), 1953–1966. https://doi.org/https://doi.org/10.1056/NEJMoa030781
- Kvernmo, T., Hartter, S., & Burger, E. (2006). A review of the receptor-binding and pharmacokinetic properties of dopamine agonists. Clinical Therapeutics, 28(8), 1065–1078. https://doi.org/https://doi.org/10.1016/j.clinthera.2006.08.004
- Li, H., Zhou, Y., Zhang, M., Wang, H., Zhao, Q., & Liu, J. (2020). Updated approaches against SARS-CoV-2. Antimicrobial Agents and Chemotherapy, 64(6), 1–7. https://doi.org/https://doi.org/10.1128/AAC.00483-20
- Li, Y. M., Wu, Z. C., Liu, K., Qi, P. F., Xu, J. P., Wei, J. C., Li, B. B., Shao, D. H., Shi, Y. Y., Qiu, Y. F., & Ma, Z. Y. (2017). Doxycycline enhances adsorption and inhibits early-stage replication of porcine reproductive and respiratory syndrome virus in vitro. FEMS Microbiology Letters, 364, 1–6.
- Lim, J., Jeon, S., Shin, H. Y., Kim, M. J., Seong, Y. M., Lee, W. J., Choe, K. W., Kang, Y. M., Lee, B., & Park, S. J. (2020). Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: The application of Lopinavir/Ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. Journal of Korean Medical Science, 35(6), e79. https://doi.org/https://doi.org/10.3346/jkms.2020.35.e89
- Lo, H. S., Hui, K. P. Y., Lai, H.-M., Khan, K. S., Kaur, S., Li, Z., Chan, A. K. N., Cheung, H. H.-Y., Ng, K. C., Ho, J. C. W., Chen, Y. W., Ma, B., Cheung, P. M.-H., Shin, D., Wang, K., Wu, K.-P., Dikic, I., Liang, P.-H., Zuo, Z., … Ng, W.-L. (2020). Simeprevir suppresses SARS-CoV-2 replication and synergizes with remdesivir. bioRxiv, 1–20. https://doi.org/https://doi.org/10.1101/2020.05.26.116020
- Lucas, J., True, L., Hawley, S., Matsumura, M., Morrissey, C., Vessella, R., & Nelson, P. (2008). The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma. The Journal of Pathology, 215(2), 118–125. https://doi.org/https://doi.org/10.1002/path.2330
- Madeira, F., Park, Y. M., Lee, J., Buso, N., Gur, T., Madhusoodanan, N., Basutkar, P., Tivey, A. R. N., Potter, S. C., Finn, R. D., & Lopez, R. (2019). The EMBL-EBI search and sequence analysis tools APIs in 2019. Nucleic Acids Research, 47(W1), W636–W641. https://doi.org/https://doi.org/10.1093/nar/gkz268
- Maksimovic-Ivanic, D., Fagone, P., McCubrey, J., Bendtzen, K., Mijatovic, S., & Nicoletti, F. (2017). HIV-protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO-hybridized derivatives? International Journal of Cancer, 140(8), 1713–1726. https://doi.org/https://doi.org/10.1002/ijc.30529
- Marberger, M. (2006). Drug Insight: 5alpha-reductase inhibitors for the treatment of benign prostatic hyperplasia. Nature Clinical Practice. Urology, 3(9), 495–503. https://doi.org/https://doi.org/10.1038/ncpuro0577
- Marder, S. R., Kramer, M., Ford, L., Eerdekens, E., Lim, P., Eerdekens, M., & Lowy, A. (2007). Efficacy and safety of paliperidone extended-release tablets: Results of a 6-week, randomized, placebo-controlled study. Biological Psychiatry, 62(12), 1363–1370. https://doi.org/https://doi.org/10.1016/j.biopsych.2007.01.017
- Montes-Grajales, D., Puerta-Guardo, H., Espinosa, D. A., Harris, E., Caicedo-Torres, W., Olivero-Verbel, J., & Martinez-Romero, E. (2020). In silico drug repurposing for the identification of potential candidate molecules against arboviruses infection. Antiviral Research, 173, 104668 https://doi.org/https://doi.org/10.1016/j.antiviral.2019.104668
- Mortier, E., Pouchot, J., Vinceneux, P., & Lalande, M. (2001). Ergotism related to interaction between nelfinavir and ergotamine. The American Journal of Medicine, 110(7), 594–594. https://doi.org/https://doi.org/10.1016/S0002-9343(01)00655-6
- Mostaghel, E. A., Nelson, P. S., Lange, P., Lin, D. W., Taplin, M. E., Balk, S., Ellis, W., Kantoff, P., Marck, B., Tamae, D., Matsumoto, A. M., True, L. D., Vessella, R., Penning, T., Merrill, R. H., Gulati, R., & Montgomery, B. (2014). Targeted androgen pathway suppression in localized prostate cancer: A pilot study. Journal of Clinical Oncology, 32(3), 229–237. https://doi.org/https://doi.org/10.1200/JCO.2012.48.6431
- Musarrat, F., Chouljenko, V., Dahal, A., Nabi, R., Chouljenkpo, T., Jois, S. D., & Kousoulas, K. (2020). The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections. Journal of Medical Virology, 1–9. https://doi.org/https://doi.org/10.1002/jmv.25985
- Owen, C. D., Lukacik, P., Strain-Damerell, C. M., Douangamath, A., Powell, A. J., Fearon, D., Brandao-Neto, J., Crawshaw, A. D., Aragao, D., Williams, M., Flaig, R., Hall, D. R., McAuley, K. E., Mazzorana, M., Stuart, D. I., von Delft, F., & Walsh, M. A. (2020). COVID-19 main protease with unliganded active site (2019-nCoV, coronavirus disease 2019, SARS-CoV-2). CSB Protein Data Bank (PDB) ID, 6Y84, 3–7. https://doi.org/https://doi.org/10.2210/pdb6Y84.
- Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kale, L., & Schulten, K. (2005). Scalable molecular dynamics with NAMD. Journal of Computational Chemistry, 26(16), 1781–1802. https://doi.org/https://doi.org/10.1002/jcc.20289
- Prajapat, M., Sarma, P., Shekhar, N., Avti, P., Sinha, S., Kaur, H., Kumar, S., Bhattacharyya, A., Kumar, H., Bansal, S., & Medhi, B. (2020). Drug targets for corona virus: A systematic review. Indian Journal of Pharmacology, 52(1), 56–65. https://doi.org/https://doi.org/10.4103/ijp.IJP_115_20
- Roehrborn, C. G., Boyle, P., Nickel, J. C., Hoefner, K., Andriole, G., Aria, A., & Investigators, A. S. (2002). Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology, 60(3), 434–441. https://doi.org/https://doi.org/10.1016/S0090-4295(02)01905-2
- Rosenthal, E., Sala, F., Chichmanian, R. M., Batt, M., & Cassuto, J. P. (1999). Ergotism related to concurrent administration of ergotamine tartrate and indinavir. Jama, 281(11), 987 https://doi.org/https://doi.org/10.1001/jama.281.11.987
- Rothan, H. A., Mohamed, Z., Paydar, M., Abd Rahman, N., & Yusof, R. (2014). Inhibitory effect of doxycycline against dengue virus replication in vitro. Archives of Virology, 159(4), 711–718. https://doi.org/https://doi.org/10.1007/s00705-013-1880-7
- Sarma, P., Shekhar, N., Prajapat, M., Avti, P., Kaur, H., Kumar, S., Singh, S., Kumar, H., Prakash, A., Dhibar, D. P., & Medhi, B. (2020). In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). Journal of Biomolecular Structure and Dynamics, 1–9.
- Scandella, E., Eriksson, K. K., Hertzig, T., Drosten, C., Chen, L., Gui, C., Luo, X., Shen, J., Shen, X., Siddell, S. G., Ludewig, B., Jiang, H., Gunther, S., & Thiel, V. (2006). Identification and evaluation of coronavirus replicase inhibitors using a replicon cell line. Advances in Experimental Medicine and Biology, 581, 609–613. https://doi.org/https://doi.org/10.1007/978-0-387-33012-9_111
- Silberstein, S. D. (1997). The pharmacology of ergotamine and dihydroergotamine. Headache, 37 (Suppl 1), S15–S25.
- Sk, M. F., Roy, R., Jonniya, N. A., Poddar, S., & Kar, P. (2020). Elucidating biophysical basis of binding of inhibitors to SARS-CoV-2 main protease by using molecular dynamics simulations and free energy calculations. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/https://doi.org/10.1080/07391102.2020.1768149
- Smilack, J. D. (1999). The tetracyclines. Mayo Clinic Proceedings, 74(7), 727–729. https://doi.org/https://doi.org/10.4065/74.7.727
- St John, S. E., Tomar, S., Stauffer, S. R., & Mesecar, A. D. (2015). Targeting zoonotic viruses: Structure-based inhibition of the 3C-like protease from bat coronavirus HKU4-The likely reservoir host to the human coronavirus that causes Middle East Respiratory Syndrome (MERS). Bioorganic & Medicinal Chemistry, 23(17), 6036–6048. https://doi.org/https://doi.org/10.1016/j.bmc.2015.06.039
- Su, S., Wong, G., Shi, W., Liu, J., Lai, A. C. K., Zhou, J., Liu, W., Bi, Y., & Gao, G. F. (2016). Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends in Microbiology, 24(6), 490–502. https://doi.org/https://doi.org/10.1016/j.tim.2016.03.003
- Tardu, M., Rahim, F., Kavakli, I. H., & Turkay, M. (2016). Milp-hyperbox classification for structure-based drug design in the discovery of small molecule inhibitors of Sirtuin6. RAIRO - Operations Research, 50(2), 387–400. https://doi.org/https://doi.org/10.1051/ro/2015042
- Thiel, V., Ivanov, K. A., Putics, Á., Hertzig, T., Schelle, B., Bayer, S., Weißbrich, B., Snijder, E. J., Rabenau, H., Doerr, H. W., Gorbalenya, A. E., & Ziebuhr, J. (2003). Mechanisms and enzymes involved in SARS coronavirus genome expression. The Journal of General Virology, 84( 9), 2305–2315. https://doi.org/https://doi.org/10.1099/vir.0.19424-0
- Thomson, A. (2005). Dutasteride: An evidence-based review of its clinical impact in the treatment of benign prostatic hyperplasia. Core Evidence, 1(2), 143–156.
- Tomar, S., Johnston, M. L., St John, S. E., Osswald, H. L., Nyalapatla, P. R., Paul, L. N., Ghosh, A. K., Denison, M. R., & Mesecar, A. D. (2015). Ligand-induced dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): Implications for nsp5 regulation and the development of antivirals. The Journal of Biological Chemistry, 290(32), 19403–19422. https://doi.org/https://doi.org/10.1074/jbc.M115.651463
- Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/https://doi.org/10.1002/jcc.21334
- Via, M. A., Chandra, H., Araki, T., Potenza, M. V., & Skamagas, M. (2010). Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 3, 43–48. https://doi.org/https://doi.org/10.2147/DMSO.S9575
- WHO. (2020). WHO Director-General’s remarks at the media briefing on 2019-nCoV. Retrieved February 11, 2020, from https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020.
- Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., Wang, Q., Xu, Y., Li, M., Li, X., Zheng, M., Chen, L., & Li, H. (2020). Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugsby computational methods. Acta Pharmaceutica Sinica B, 10(5), 766–788. https://doi.org/https://doi.org/10.1016/j.apsb.2020.02.008
- Wu, F., Zhao, S., Yu, B., Chen, Y. M., Wang, W., Song, Z. G., Hu, Y., Tao, Z. W., Tian, J. H., Pei, Y. Y., Yuan, M. L., Zhang, Y. L., Dai, F. H., Liu, Y., Wang, Q. M., Zheng, J. J., Xu, L., Holmes, E. C., & Zhang, Y. Z. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579(7798), 265–269. https://doi.org/https://doi.org/10.1038/s41586-020-2202-3
- Wu, Z. C., Wang, X., Wei, J. C., Li, B. B., Shao, D. H., Li, Y. M., Liu, K., Shi, Y. Y., Zhou, B., Qiu, Y. F., & Ma, Z. Y. (2015). Antiviral activity of doxycycline against vesicular stomatitis virus in vitro. FEMS Microbiology Letters, 362, 1–7.
- Xu, X., Liu, Y., Weiss, S., Arnold, E., Sarafianos, S. G., & Ding, J. (2003). Molecular model of SARS coronavirus polymerase: Implications for biochemical functions and drug design. Nucleic Acids Research, 31(24), 7117–7130. https://doi.org/https://doi.org/10.1093/nar/gkg916
- Yamamoto, N., Yang, R. G., Yoshinaka, Y., Amari, S., Nakano, T., Cinatl, J., Rabenau, H., Doerr, H. W., Hunsmann, G., Otaka, A., Tamamura, H., Fujii, N., & Yamamoto, N. (2004). HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus. Biochemical and Biophysical Research Communications, 318(3), 719–725. https://doi.org/https://doi.org/10.1016/j.bbrc.2004.04.083
- Yu, X. J., Liang, M. F., Zhang, S. Y., Liu, Y., Li, J. D., Sun, Y. L., Zhang, L., Zhang, Q. F., Popov, V. L., Li, C., Qu, J., Li, Q., Zhang, Y. P., Hai, R., Wu, W., Wang, Q., Zhan, F. X., Wang, X. J., Kan, B., … Li, D. X. (2011). Fever with thrombocytopenia associated with a novel bunyavirus in China. The New England Journal of Medicine, 364(16), 1523–1532. https://doi.org/https://doi.org/10.1056/NEJMoa1010095
- Yuan, S., Chan, J. F., den-Haan, H., Chik, K. K., Zhang, A. J., Chan, C. C., Poon, V. K., Yip, C. C., Mak, W. W., Zhu, Z., Zou, Z., Tee, K. M., Cai, J. P., Chan, K. H., de la Pena, J., Perez-Sanchez, H., Ceron-Carrasco, J. P., & Yuen, K. Y. (2017). Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo. Antiviral Research, 145, 33–43. https://doi.org/https://doi.org/10.1016/j.antiviral.2017.07.007
- Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012). Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. The New England Journal of Medicine, 367(19), 1814–1820. https://doi.org/https://doi.org/10.1056/NEJMoa1211721
- Zhou, P., Yang, X. L., Wang, X. G., Hu, B., Zhang, L., Zhang, W., Si, H. R., Zhu, Y., Li, B., Huang, C. L., Chen, H. D., Chen, J., Luo, Y., Guo, H., Jiang, R. D., Liu, M. Q., Chen, Y., Shen, X. R., Wang, X., … Shi, Z. L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270–273. https://doi.org/https://doi.org/10.1038/s41586-020-2012-7
- Ziebuhr, J. (2004). Molecular biology of severe acute respiratory syndrome coronavirus. Current Opinion in Microbiology, 7(4), 412–419. https://doi.org/https://doi.org/10.1016/j.mib.2004.06.007
- Ziebuhr, J. (2005). The coronavirus replicase. Current Topics in Microbiology and Immunology, 287, 57–94. https://doi.org/https://doi.org/10.1007/3-540-26765-4_3